ストックスクリーナーアプリを入手
4.41
2.32%
0.10
アフターアワーズ：
4.41
前日終値:
$4.31
開ける：
$4.36
24時間の取引高:
152.10K
Relative Volume:
0.98
時価総額：
$249.30M
収益：
$34.16M
当期純損益:
$-98.43M
株価収益率:
-1.8846
EPS:
-2.34
ネットキャッシュフロー:
$-119.33M
1週間 パフォーマンス:
+8.35%
1か月 パフォーマンス:
-9.82%
6か月 パフォーマンス:
+5.00%
1年 パフォーマンス:
-42.13%
1日の値動き範囲:
$4.15
$4.61
1週間の範囲:
$3.94
$4.69
52週間の値動き範囲:
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
名前
Foghorn Therapeutics Inc
セクター
電話
617-586-3100
住所
500 TECHNOLOGY SQUARE, CAMBRIDGE
FHTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.41 | 243.64M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-17 | 再開されました | B. Riley Securities | Buy |
| 2025-04-23 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-01-30 | 開始されました | B. Riley Securities | Buy |
| 2024-09-03 | 開始されました | Jefferies | Buy |
| 2024-08-19 | 開始されました | Evercore ISI | Outperform |
| 2023-03-28 | 開始されました | BofA Securities | Buy |
| 2023-01-05 | 開始されました | BMO Capital Markets | Outperform |
| 2021-11-22 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-17 | 開始されました | Cowen | Outperform |
| 2020-11-17 | 開始されました | Goldman | Buy |
| 2020-11-17 | 開始されました | Morgan Stanley | Overweight |
| 2020-11-17 | 開始されました | Wedbush | Outperform |
すべてを表示
Foghorn Therapeutics Inc (FHTX) 最新ニュース
Foghorn Therapeutics shares progress on three protein degrader programs - BioWorld MedTech
Why Foghorn Therapeutics Inc. is moving todayQuarterly Profit Review & Reliable Price Action Trade Plans - newser.com
Can swing trading help recover from Foghorn Therapeutics Inc. lossesJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.Weekly Stock Report & High Yield Stock Recommendations - newser.com
Why Foghorn Therapeutics Inc. stock could outperform in 2025Earnings Trend Report & Weekly High Return Forecasts - newser.com
Is Foghorn Therapeutics Inc. stock bottoming out2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Applying big data sentiment scoring on Foghorn Therapeutics Inc.Analyst Downgrade & High Conviction Trade Alerts - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.Quarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Will Foghorn Therapeutics Inc. continue its uptrendMarket Performance Report & Precise Buy Zone Tips - newser.com
Is Foghorn Therapeutics Inc. stock safe for conservative investorsMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
Has Foghorn Therapeutics Inc. formed a bullish divergencePortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Foghorn Therapeutics advances ARID1B, CBP, EP300 development - Traders Union
Foghorn Therapeutics Announces Key Pipeline Updates - TipRanks
Foghorn Therapeutics Inc Announces Pipeline Updates for Degrader Programs - TradingView
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs - Yahoo Finance
Momentum divergence signals in Foghorn Therapeutics Inc. chartQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - newser.com
How risky is Foghorn Therapeutics Inc. stock nowEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
Volatility clustering patterns for Foghorn Therapeutics Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
How moving averages guide Foghorn Therapeutics Inc. trading2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Foghorn Therapeutics (FHTX) Expected to Announce Earnings on Monday - MarketBeat
Foghorn Therapeutics Inc (FHTX) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):